The expansion of the Lidocaine Patches Market is projected to be aided by the increasing number of generic authorised products

 Lidocaine Patches Market Dynamics

The expansion of the lidocaine patches market is projected to be aided by the increasing number of generic authorised products on the market. Endo Pharmaceuticals' Lidoderm patent has expired, providing a chance for market players to produce a generic version of the lidocaine patch. For example, Mylan Pharmaceuticals, Inc. released a generic version of Endo Pharmaceuticals' Lidoderm in the United States in 2015. Galen US Incorporated received FDA approval for Synera, lidocaine, and tetracaine topical patches for use in the United States in 2014.


Furthermore, in order to preserve their market leadership, firms are incorporating sophisticated technology into lidocaine patches. For example, Gregory Pharmaceutical Holdings, Inc. released Lidocare in 2016, which is the first and only water-free patch. Lidocare is a novel over-the-counter/non-prescription lidocaine pain patch that is in the process of being patented. Sorrento Therapeutics, Inc., a Scilex Pharmaceuticals Inc. affiliate, got FDA approval for ZTlido 1.8 percent in February 2018, using the company's unique adhesion technology. In addition, firms are conducting clinical trials to increase the use of lidocaine patches for diseases and illnesses. For example, Endo Pharmaceuticals, Inc. is conducting a clinical trial for the use of lidocaine patches in osteoarthritis, chronisis, and other conditions.

During the projected period, the market for lidocaine patches is expected to develop due to an increase in the prevalence of shingles. Shingles, commonly known as herpes zoster, causes chronic pain called Post Herpetic Neuralgia (PHN), which is treated with lidocaine patches. According to the Centers for Disease Control and Prevention (CDC), approximately one-third of the overall U.S. population gets shingles at some point in their lives, implying that nearly one million Americans have shingles each year. Furthermore, the CDC estimates that 10 to 15% of persons with shingles infection will develop PHN.

Lidocaine Patches Market - Regional Analysis

Coherent Market Insights has segmented the lidocaine patches market into North America, Latin America, Europe, Asia Pacific, the Middle East, and Africa. Because of the significant number of product releases by regional companies and strategic alliances among market participants to introduce their product in the regional market, the North American lidocaine patches market retains a leading position. Galen, for example, purchased Synera patch, a Nuvo Research product, in order to commercialise it in the US lidocaine patch market.Furthermore, reimbursement policies for lidocaine patches in North America are boosting market expansion. Furthermore, the Asia Pacific Lidocaine Patches Market is predicted to rise rapidly due to an increase in the frequency of herpes zoster in the region and a lack of preventive shingles vaccination, which is expected to propel the lidocaine patches market forward.

Comments

Post a Comment

Popular posts from this blog

One of the primary factors driving the Worldwide Frosting and Icing Market is the rising demand for cakes and pastries.

Image
  Market Dynamics The increased demand for cakes and pastries is one of the key reasons driving the global frosting and icing market . According to Agriculture and Agri-Food Canada, the value of cakes sold in the United Kingdom increased by an average of 2% every year from 2012 to 2017, outpacing the CAGR by 1.5 percent (2007-2012). Furthermore, an increase in the number of bakeries as a result of increased urbanisation and rising income, which leads to a burgeoning food sector, is fueling the expansion of the frosting and icing market. In 2015, India's food processing business was valued at US$ 258 billion, according to the India Brand Equity Foundation (IBEF), ranking fifth in terms of consumption, output, and exports. Health issues, such as increased obesity, are, however, restraining market growth. In 2017, 36.5 percent of adults in the United States were obese, according to the Centers for Disease Control and Prevention (CDC), which impeded market expansion. To tackle this, a ...
Read more

Orthopedic Power Tools Market predicted to be growing at a CAGR of 3.50 percent over the forecast period (2020-2027)

Image
Various orthopaedic illnesses in the musculoskeletal systems, such as musculoskeletal trauma, spine diseases, musculoskeletal injuries, and infections, are treated by orthopaedics. Orthopedic power tools are lightweight, user-friendly, and easy to handle when performing orthopaedic surgery when compared to traditional heavy orthopaedic tools. Electric powered orthopaedic tools, battery operated power systems, and pneumatic power tools are the three types of orthopaedic power tools. In 2020, the global orthopaedic power tools market is predicted to be worth US$ 943.8 million, growing at a CAGR of 3.50 percent over the forecast period (2020-2027). One of the reasons predicted to drive market expansion during the forecast period is the rising frequency of spinal injuries. According to a report issued by the National Spinal Cord Injury Statistical Center in 2018, the incidence of spinal cord injury in the United States is roughly 54 instances per one million individuals, with around 17,70...
Read more

The Acute Bacterial Skin and Skin Structure Infections (ABSSSI) Market will continue to increase as the number of ambulatory individuals seeking treatment for skin and skin structure infections rises

Image
Acute Bacterial Skin and Skin Structure Infections (ABSSSI) are infections of the epidermis, dermis, and subcutaneous tissues that affect the skin and soft tissues. ABSSSI is defined by the US FDA as lesions having cellulitis/erysipelas, wound infections, and large cutaneous abscesses with a surface area of at least 75 cm2. ABSSSI is caused by pathogens such as Methicillin-sensitive Staphylococcus aureus (MSSA), Methicillin-resistant Staphylococcus aureus (MRSA), Beta-hemolytic Streptococcus, E. coli, Enterococcus faecalis, and Pseudomonas aeruginosa. The rising incidence of drug-resistant strains, particularly in Staphylococcus spp. and Enterococcus spp., makes this infection challenging to treat. The ABSSSI market is predicted to grow at a steady pace, thanks to an increasing number of patients suffering from these conditions and a significant number of pipeline treatments expected to be authorised during the forecast period. Acute Bacterial Skin and Skin Structure Infections (ABSSSI...
Read more